Merck KGaA sells allergy unit to Dermapharm, keeps autoinjector project
February 19, 2020 at 10:37 AM EST
German drugmaker Merck KGaA agreed to sell its allergy business Allergopharma to Dermapharm SE for an undisclosed price but will continue to develop an autoinjector to treat allergic shock.
